Company intelligence / Profile preview

Merkava Holdings

Los Angeles / Beverly Hills, California, United Statesmerkavaholdings.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Merkava Holdings is the investment arm of the Philip E. Werthman Trust. It focuses on investing in and supporting early and mid-stage companies across sectors including health & wellness, biotech, pharma, software, wireless technology, aerospace & defense, and real estate. The firm leverages Dr. Philip Werthman's extensive network to help portfolio companies grow globally through capital infusion and strategic relationships.

Industry: Investors

Drug pipeline

1 asset

GTB-3550

Phase 1/2

Indications: Acute myeloid leukemia, Myelodysplastic syndrome

Beyond the preview

Go deeper on Merkava Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merkava Holdings.

Explore the full profile